| Human coagulation factor VIII |
II-28286/30.01.2015 |
Beriate, Powder and solvent for solution for injection/infusion, 250, IU, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
189.68 |
37.94 |
227.62 |
4% |
7.59 |
197.27 |
39.45 |
236.72 |
16% |
25 |
222.27 |
44.45 |
266.72 |
|
НСР-6760/23.07.2015 |
08.08.2015 |
08.08.2015 |
Неактивен |
4045 |
| Human coagulation factor VIII |
II-28287/30.01.2015 |
Beriate, Powder and solvent for solution for injection/infusion, 500, IU, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
340.31 |
68.06 |
408.37 |
4% |
10 |
350.31 |
70.06 |
420.37 |
16% |
25 |
375.31 |
75.06 |
450.37 |
|
НСР-6760/23.07.2015 |
08.08.2015 |
08.08.2015 |
Неактивен |
4046 |
| Human coagulation factor VIII |
II-28288/30.01.2015 |
Beriate, Powder and solvent for solution for injection/infusion, 1000, IU, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
744.45 |
148.89 |
893.34 |
4% |
10 |
754.45 |
150.89 |
905.34 |
16% |
25 |
779.45 |
155.89 |
935.34 |
|
НСР-6760/23.07.2015 |
08.08.2015 |
08.08.2015 |
Неактивен |
4047 |
| Human coagulation factor VIII |
II-28287/30.01.2015 |
Beriate, Powder and solvent for solution for injection/infusion, 500, IU, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
340.31 |
68.06 |
408.37 |
4% |
10 |
350.31 |
70.06 |
420.37 |
16% |
25 |
375.31 |
75.06 |
450.37 |
|
НСР-6760/23.07.2015 |
08.08.2015 |
08.08.2015 |
Неактивен |
4046 |
| Human coagulation factor VIII |
II-28286/30.01.2015 |
Beriate, Powder and solvent for solution for injection/infusion, 250, IU, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
189.68 |
37.94 |
227.62 |
4% |
7.59 |
197.27 |
39.45 |
236.72 |
16% |
25 |
222.27 |
44.45 |
266.72 |
|
НСР-6760/23.07.2015 |
08.08.2015 |
08.08.2015 |
Неактивен |
4045 |
| c1-inhibitor, plasma derived |
20080293 |
Berinert 500 IU, Powder and solvent for solution for injection/infusion, 500 IU, IU, Pack: 1 vial |
CSL Behring GmbH, Германия |
CSL Behring GmbH, E-mail-von-Behring-Str. 76,35041 Marburg, Германия |
866.71 |
173.34 |
1040.05 |
4% |
10 |
876.71 |
175.34 |
1052.05 |
16% |
25 |
901.71 |
180.34 |
1082.05 |
|
HCР-22/31.05.2013; НСР-15137/02.03.2018; НСР-18824/30.05.2019 |
14.06.2019 |
02.07.2019 |
Активен |
1848 |
| c1-inhibitor, plasma derived |
20080293 |
Berinert 500 IU, Powder and solvent for solution for injection/infusion, 500 IU, IU, Pack: 1 vial |
CSL Behring GmbH, Германия |
CSL Behring GmbH, E-mail-von-Behring-Str. 76,35041 Marburg, Германия |
866.71 |
173.34 |
1040.05 |
4% |
10 |
876.71 |
175.34 |
1052.05 |
16% |
25 |
901.71 |
180.34 |
1082.05 |
|
HCР-22/31.05.2013; НСР-15137/02.03.2018; НСР-18824/30.05.2019 |
14.06.2019 |
02.07.2019 |
Неактивен |
1848 |
| c1-inhibitor, plasma derived |
20080293 |
Berinert 500 IU, Powder and solvent for solution for injection/infusion, 500 IU, IU, Pack: 1 vial |
CSL Behring GmbH, Германия |
CSL Behring GmbH, E-mail-von-Behring-Str. 76,35041 Marburg, Германия |
885.4 |
177.08 |
1062.48 |
4% |
10 |
895.4 |
179.08 |
1074.48 |
16% |
25 |
920.4 |
184.08 |
1104.48 |
|
HCР-22/31.05.2013; НСР-15137/02.03.2018 |
17.03.2018 |
02.04.2018 |
Неактивен |
1848 |
| c1-inhibitor, plasma derived |
20080293 |
Berinert 500 IU, Powder and solvent for solution for injection/infusion, 500 IU, IU, Pack: 1 vial |
CSL Behring GmbH, Германия |
CSL Behring GmbH, E-mail-von-Behring-Str. 76,35041 Marburg, Германия |
898.2 |
179.64 |
1077.84 |
4% |
10 |
908.2 |
181.64 |
1089.84 |
16% |
25 |
933.2 |
186.64 |
1119.84 |
|
HCР-22/31.05.2013 |
02.06.2013 |
02.06.2013 |
Неактивен |
1848 |
| Enalapril |
20020461 |
Berlipril, Tablet, 20, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany |
4.79 |
0.96 |
5.75 |
7% |
0.34 |
5.13 |
1.03 |
6.16 |
20% |
0.96 |
6.09 |
1.22 |
7.31 |
промяна на обстоятелства НСР-4529/22.08.2014( в сила от 08.09.2014), промяна обстоятелства НСР-9893/29.07.2016; НСР-17104/26.10.2018 |
КЦ-48/21.04.2008; НСР-13083/29.06.2017 |
14.07.2017 |
02.12.2018 |
Активен |
29 |
| Enalapril |
20020460 |
Berlipril, Tablet, 10, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany; Menarini - Von Heyden GmbH, Germany |
3.03 |
0.61 |
3.64 |
7% |
0.21 |
3.24 |
0.65 |
3.89 |
20% |
0.61 |
3.85 |
0.77 |
4.62 |
корекционно решение НСР-6578/01.07.2015, промяна обстоятелства НСР-9894/29.07.2016 |
НСР-6499/18.06.2015 |
04.07.2015 |
02.09.2016 |
Активен |
28 |
| Enalapril |
9600019 |
Berlipril, Tablet, 5, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany; Menarini - Von Heyden GmbH, Germany |
2.72 |
0.54 |
3.26 |
7% |
0.19 |
2.91 |
0.58 |
3.49 |
20% |
0.54 |
3.45 |
0.69 |
4.14 |
промяна на обстоятелства НСР-4465/15.08.2014( в сила от 01.09.2014), НСР-9895/29.07.2016 |
КЦ-48/21.04.2008 |
23.05.2008 |
02.09.2016 |
Активен |
27 |
| Enalapril |
20020461 |
Berlipril, Tablet, 20, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany |
4.79 |
0.96 |
5.75 |
7% |
0.34 |
5.13 |
1.03 |
6.16 |
20% |
0.96 |
6.09 |
1.22 |
7.31 |
промяна на обстоятелства НСР-4529/22.08.2014( в сила от 08.09.2014), промяна обстоятелства НСР-9893/29.07.2016; НСР-17104/26.10.2018 |
КЦ-48/21.04.2008; НСР-13083/29.06.2017 |
14.07.2017 |
02.12.2018 |
Неактивен |
29 |
| Enalapril |
20020460 |
Berlipril, Tablet, 10, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany; Menarini - Von Heyden GmbH, Germany |
3.03 |
0.61 |
3.64 |
7% |
0.21 |
3.24 |
0.65 |
3.89 |
20% |
0.61 |
3.85 |
0.77 |
4.62 |
корекционно решение НСР-6578/01.07.2015, промяна обстоятелства НСР-9894/29.07.2016 |
НСР-6499/18.06.2015 |
04.07.2015 |
02.09.2016 |
Неактивен |
28 |
| Enalapril |
9600019 |
Berlipril, Tablet, 5, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany; Menarini - Von Heyden GmbH, Germany |
2.72 |
0.54 |
3.26 |
7% |
0.19 |
2.91 |
0.58 |
3.49 |
20% |
0.54 |
3.45 |
0.69 |
4.14 |
промяна на обстоятелства НСР-4465/15.08.2014( в сила от 01.09.2014), НСР-9895/29.07.2016 |
КЦ-48/21.04.2008 |
23.05.2008 |
02.09.2016 |
Неактивен |
27 |
| Enalapril |
20020461 |
Berlipril, Tablet, 20, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany; Menarini - Von Heyden GmbH, Germany |
4.79 |
0.96 |
5.75 |
7% |
0.34 |
5.13 |
1.03 |
6.16 |
20% |
0.96 |
6.09 |
1.22 |
7.31 |
промяна на обстоятелства НСР-4529/22.08.2014( в сила от 08.09.2014), промяна обстоятелства НСР-9893/29.07.2016 |
КЦ-48/21.04.2008; НСР-13083/29.06.2017 |
14.07.2017 |
02.08.2017 |
Неактивен |
29 |
| Enalapril |
20020461 |
Berlipril, Tablet, 20, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany; Menarini - Von Heyden GmbH, Germany |
5.2 |
1.04 |
6.24 |
7% |
0.36 |
5.56 |
1.11 |
6.67 |
20% |
1.04 |
6.6 |
1.32 |
7.92 |
промяна на обстоятелства НСР-4529/22.08.2014( в сила от 08.09.2014), промяна обстоятелства НСР-9893/29.07.2016 |
КЦ-48/21.04.2008 |
23.05.2008 |
02.09.2016 |
Неактивен |
29 |
| Enalapril |
II-0177/06.07.2007 |
Berlipril, Tablet, 5, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany; Menarini - Von Heyden GmbH, Germany |
2.72 |
0.54 |
3.26 |
7% |
0.19 |
2.91 |
0.58 |
3.49 |
20% |
0.54 |
3.45 |
0.69 |
4.14 |
промяна на обстоятелства НСР-4465/15.08.2014( в сила от 01.09.2014) |
КЦ-48/21.04.2008 |
23.05.2008 |
23.05.2008 |
Неактивен |
27 |
| Enalapril |
II-0178/06.07.2007 |
Berlipril, Tablet, 10, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany; Menarini - Von Heyden GmbH, Germany |
3.03 |
0.61 |
3.64 |
7% |
0.21 |
3.24 |
0.65 |
3.89 |
20% |
0.61 |
3.85 |
0.77 |
4.62 |
корекционно решение НСР-6578/01.07.2015 |
НСР-6499/18.06.2015 |
04.07.2015 |
04.07.2015 |
Неактивен |
28 |
| Enalapril |
II-0179/06.07.2007 |
Berlipril, Tablet, 20, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany; Menarini - Von Heyden GmbH, Germany |
5.2 |
1.04 |
6.24 |
7% |
0.36 |
5.56 |
1.11 |
6.67 |
20% |
1.04 |
6.6 |
1.32 |
7.92 |
промяна на обстоятелства НСР-4529/22.08.2014( в сила от 08.09.2014) |
КЦ-48/21.04.2008 |
23.05.2008 |
23.05.2008 |
Неактивен |
29 |
| Enalapril |
II-0178/06.07.2007 |
Berlipril, Tablet, 10, mg, Pack: 30 |
Berlin-Chemie AG (Menarini Group), Германия |
Berlin-Chemie AG (Menarini Group), Glienicker Weg 125, 12489 Berlin, Germany; Menarini - Von Heyden GmbH, Germany |
3.09 |
0.62 |
3.71 |
7% |
0.22 |
3.31 |
0.66 |
3.97 |
20% |
0.62 |
3.93 |
0.79 |
4.72 |
промяна на обстоятелства НСР-4466/15.08.2014( в сила от 01.09.2014) |
КЦ-48/21.04.2008 |
23.05.2008 |
23.05.2008 |
Неактивен |
28 |
| Inotuzumab ozogamicin |
EU/1/17/12 00/001 |
BESPONSA, Powder for concentrate for solution for infusion, 1, mg, Pack: 1 vial |
Pfizer Europe MA EEIG, Белгия |
Pfizer Ireland Pharmaceuticals, Ирландия |
18375.32 |
3675.06 |
22050.38 |
4% |
10 |
18385.32 |
3677.06 |
22062.38 |
16% |
25 |
18410.32 |
3682.06 |
22092.38 |
|
НСР-17555/19.12.2018 предварително изпълнение; НСР-19648/29.08.2019 |
13.09.2019 |
02.10.2019 |
Активен |
16071 |
| Inotuzumab ozogamicin |
EU/1/17/12 00/001 |
BESPONSA, Powder for concentrate for solution for infusion, 1, mg, Pack: 1 vial |
Pfizer Europe MA EEIG, Белгия |
Pfizer Ireland Pharmaceuticals, Ирландия |
18635.85 |
3727.17 |
22363.02 |
4% |
10 |
18645.85 |
3729.17 |
22375.02 |
16% |
25 |
18670.85 |
3734.17 |
22405.02 |
|
НСР-17555/19.12.2018 предварително изпълнение |
19.12.2018 |
02.01.2019 |
Неактивен |
16071 |
| Inotuzumab ozogamicin |
EU/1/17/12 00/001 |
BESPONSA, Powder for concentrate for solution for infusion, 1, mg, Pack: 1 vial |
Pfizer Europe MA EEIG, Белгия |
Pfizer Ireland Pharmaceuticals, Ирландия |
18635.85 |
3727.17 |
22363.02 |
4% |
10 |
18645.85 |
3729.17 |
22375.02 |
16% |
25 |
18670.85 |
3734.17 |
22405.02 |
|
НСР-17555/19.12.2018 предварително изпълнение |
19.12.2018 |
02.01.2019 |
Неактивен |
16071 |
| Metoprolol |
20100091 |
BETABLOCKADE, Prolonged release tablet, 100, mg, Pack: 30 |
Чайкафарма Висококачествените лекарства АД, България |
"Чайкафарма Висококачествените Лекарства" АД гр. Пловдив, България |
6.92 |
1.38 |
8.3 |
7% |
0.48 |
7.4 |
1.48 |
8.88 |
20% |
1.38 |
8.78 |
1.76 |
10.54 |
|
НСР-3869/20.06.2014; НСР-18110/07.03.2019 |
22.03.2019 |
02.04.2019 |
Активен |
2952 |